These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 1824837

  • 1. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay.
    Tsubouchi H, Niitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N, Sakiyama O, Takahashi K, Kimoto M, Kawakami S.
    Hepatology; 1991 Jan; 13(1):1-5. PubMed ID: 1824837
    [Abstract] [Full Text] [Related]

  • 2. [Determination and clinical significance of human hepatocyte growth factor in serum].
    Takemura M, Furuta N, Nakamura S, Okuno M, Seishima M, Noma A, Sugihara J, Murakami N, Sugiyama H, Moriwaki H.
    Rinsho Byori; 1992 Nov; 40(11):1168-72. PubMed ID: 1307623
    [Abstract] [Full Text] [Related]

  • 3. Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure.
    Odeh M, Sabo E, Srugo I, Oliven A.
    Liver Int; 2004 Apr; 24(2):110-6. PubMed ID: 15078474
    [Abstract] [Full Text] [Related]

  • 4. Changes in serum human hepatocyte growth factor levels after transcatheter arterial embolization and partial hepatectomy.
    Kaneko A, Hayashi N, Tanaka Y, Ito T, Kasahara A, Kubo M, Mukuda T, Fusamoto H, Kamada T.
    Am J Gastroenterol; 1992 Aug; 87(8):1014-7. PubMed ID: 1322635
    [Abstract] [Full Text] [Related]

  • 5. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.
    Shiota G, Umeki K, Okano J, Kawasaki H.
    J Med; 1995 Aug; 26(5-6):295-308. PubMed ID: 8721905
    [Abstract] [Full Text] [Related]

  • 6. Evidence for the presence of an inactive precursor of human hepatocyte growth factor in plasma and sera of patients with liver diseases.
    Arakaki N, Kawakami S, Nakamura O, Ohnishi T, Miyazaki H, Ishii T, Tsubouchi H, Daikuhara Y.
    Hepatology; 1995 Dec; 22(6):1728-34. PubMed ID: 7489981
    [Abstract] [Full Text] [Related]

  • 7. Serum hepatocyte growth factor levels in liver diseases: clinical implications.
    Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T.
    Hepatology; 1995 Jan; 21(1):106-12. PubMed ID: 7806142
    [Abstract] [Full Text] [Related]

  • 8. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases.
    Yamagamim H, Moriyama M, Matsumura H, Aoki H, Shimizu T, Saito T, Kaneko M, Shioda A, Tanaka N, Arakawa Y.
    Cancer; 2002 Aug 15; 95(4):824-34. PubMed ID: 12209727
    [Abstract] [Full Text] [Related]

  • 9. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
    Wu F, Wu L, Zheng S, Ding W, Teng L, Wang Z, Ma Z, Zhao W.
    Dig Liver Dis; 2006 Jul 15; 38(7):490-7. PubMed ID: 16627020
    [Abstract] [Full Text] [Related]

  • 10. Portal serum human hepatocyte growth factor levels after partial hepatectomy.
    Higaki I, Yamazaki O, Matsuyama M, Horii K, Kawai S, Hirohashi K, Kinoshita H.
    Hepatogastroenterology; 1999 Jul 15; 46(26):1078-82. PubMed ID: 10370670
    [Abstract] [Full Text] [Related]

  • 11. Clinical significance of serum hepatocyte growth factor levels in liver diseases.
    Hioki O, Watanabe A, Minemura M, Tsuchida T.
    J Med; 1993 Jul 15; 24(1):35-46. PubMed ID: 7684768
    [Abstract] [Full Text] [Related]

  • 12. Clinical significance of serum soluble Fas ligand in patients with acute self-limited and fulminant hepatitis.
    Shiota G, Oyama K, Noguchi N, Takano Y, Kitaoka S, Kawasaki H.
    Res Commun Mol Pathol Pharmacol; 1998 Jul 15; 101(1):3-12. PubMed ID: 9755839
    [Abstract] [Full Text] [Related]

  • 13. Serum hepatocyte growth factor in acute hepatic failure in comparison with acute hepatitis.
    Shiota G, Okano J, Umeki K, Kawasaki H, Kawamoto T, Nakamura T.
    Res Commun Mol Pathol Pharmacol; 1994 Aug 15; 85(2):157-62. PubMed ID: 7994560
    [Abstract] [Full Text] [Related]

  • 14. Hepatocyte growth factor (HGF) in patients with hepatitis B and meningitis.
    Ozden M, Kalkan A, Demirdag K, Denk A, Kilic SS.
    J Infect; 2004 Oct 15; 49(3):229-35. PubMed ID: 15337340
    [Abstract] [Full Text] [Related]

  • 15. Human hepatocyte growth factor in blood of patients with fulminant hepatic failure. I. Clinical aspects.
    Tsubouchi H, Hirono S, Gohda E, Nakayama H, Takahashi K, Sakiyama O, Kimoto M, Kawakami S, Miyoshi H, Kubozono O.
    Dig Dis Sci; 1991 Jun 15; 36(6):780-4. PubMed ID: 1827761
    [Abstract] [Full Text] [Related]

  • 16. Serum hepatocyte growth factor and vascular endothelial growth factor in children with acute liver failure.
    Aw MM, Mitry RR, Hughes RD, Dhawan A.
    J Pediatr Gastroenterol Nutr; 2007 Feb 15; 44(2):224-7. PubMed ID: 17255836
    [Abstract] [Full Text] [Related]

  • 17. The role of HGF-SF in animal and human hepatic physiology and pathology.
    Tsubouchi H, Gohda E, Strain AJ, Daikuhara Y.
    EXS; 1993 Feb 15; 65():251-74. PubMed ID: 8422546
    [Abstract] [Full Text] [Related]

  • 18. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS, Zheng SS, Wu LJ, Ding W, Ma ZM, Wang ZM, Teng LS, Zhao WH.
    Zhonghua Wai Ke Za Zhi; 2006 May 01; 44(9):603-8. PubMed ID: 16784653
    [Abstract] [Full Text] [Related]

  • 19. Relationship between tumor necrosis factor-alpha and ammonia in patients with hepatic encephalopathy due to chronic liver failure.
    Odeh M, Sabo E, Srugo I, Oliven A.
    Ann Med; 2005 May 01; 37(8):603-12. PubMed ID: 16338762
    [Abstract] [Full Text] [Related]

  • 20. Increased level of serum hepatocyte growth factor/scatter factor in liver cancer is associated with tumor metastasis.
    Junbo H, Li Q, Zaide W, Yunde H.
    In Vivo; 1999 May 01; 13(2):177-80. PubMed ID: 10363175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.